India · Delayed Price · Currency is INR Cian Healthcare Statistics
Total Valuation
Cian Healthcare has a market cap or net worth of INR 334.75 million. The enterprise value is 609.37 million.
| Market Cap | 334.75M |
| Enterprise Value | 609.37M |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cian Healthcare has 25.00 million shares outstanding. The number of shares has decreased by -0.04% in one year.
| Current Share Class | 25.00M |
| Shares Outstanding | 25.00M |
| Shares Change (YoY) | -0.04% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 81.74% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| PB Ratio | 3.92 |
| P/TBV Ratio | 3.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 3.36.
| Current Ratio | 0.78 |
| Quick Ratio | 0.47 |
| Debt / Equity | 3.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -12.50 |
| Interest Coverage | -45.09 |
Financial Efficiency
Return on equity (ROE) is -113.92% and return on invested capital (ROIC) is -26.86%.
| Return on Equity (ROE) | -113.92% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -26.86% |
| Return on Capital Employed (ROCE) | -29.84% |
| Weighted Average Cost of Capital (WACC) | 4.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 185 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, Cian Healthcare has paid 1.12 million in taxes.
| Income Tax | 1.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +285.88% in the last 52 weeks. The beta is 0.52, so Cian Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +285.88% |
| 50-Day Moving Average | 6.64 |
| 200-Day Moving Average | 4.83 |
| Relative Strength Index (RSI) | 94.11 |
| Average Volume (20 Days) | 28,922 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cian Healthcare had revenue of INR 294.69 million and -232.93 million in losses. Loss per share was -9.32.
| Revenue | 294.69M |
| Gross Profit | 69.41M |
| Operating Income | -96.68M |
| Pretax Income | -231.81M |
| Net Income | -232.93M |
| EBITDA | -57.53M |
| EBIT | -96.68M |
| Loss Per Share | -9.32 |
Balance Sheet
The company has 11.96 million in cash and 286.59 million in debt, with a net cash position of -274.62 million or -10.98 per share.
| Cash & Cash Equivalents | 11.96M |
| Total Debt | 286.59M |
| Net Cash | -274.62M |
| Net Cash Per Share | -10.98 |
| Equity (Book Value) | 85.36M |
| Book Value Per Share | 3.41 |
| Working Capital | -62.74M |
Cash Flow
In the last 12 months, operating cash flow was -14.72 million and capital expenditures -8.21 million, giving a free cash flow of -22.92 million.
| Operating Cash Flow | -14.72M |
| Capital Expenditures | -8.21M |
| Depreciation & Amortization | 39.15M |
| Net Borrowing | -143.49M |
| Free Cash Flow | -22.92M |
| FCF Per Share | -0.92 |
Margins
Gross margin is 23.55%, with operating and profit margins of -32.81% and -79.04%.
| Gross Margin | 23.55% |
| Operating Margin | -32.81% |
| Pretax Margin | -78.66% |
| Profit Margin | -79.04% |
| EBITDA Margin | -19.52% |
| EBIT Margin | -32.81% |
| FCF Margin | n/a |
Dividends & Yields
Cian Healthcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.04% |
| Shareholder Yield | 0.04% |
| Earnings Yield | -69.58% |
| FCF Yield | -6.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |